Syndax Pharmaceuticals, Inc.
USD21.78
+0.47 (+2.21%)
CEO
Michael A. Metzger
IPO Date
2016-03-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$21.20
Prev. Close
$21.31
Day Low
$20.86
Day High
$22.05
52W Low
$8.59
52W High
$25.59
Market Cap
$1.93B
Volume
4.23M
| -3.6 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -37.8% | -34.2% | 0.00 | 10.00 | -7.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -31.9% | -30.0% | 0.00 | 16.85 | -10.4 |
| 31 Dec 2021 | FY | 100.0% | 17.8% | 6.1% | 5.5% | 0.05 | 21.68 | 45.7 |
| 31 Dec 2020 | FY | 100.0% | -4816.7% | -29.0% | -24.3% | 0.08 | 15.84 | -12.6 |
| 31 Dec 2019 | FY | 100.0% | -3688.5% | -177.1% | -88.1% | 0.03 | 3.39 | -4.8 |
| 31 Dec 2018 | FY | 100.0% | -4875.5% | -139.4% | -88.1% | 0.00 | 5.18 | -1.5 |
| 31 Dec 2017 | FY | 100.0% | -2884.3% | -58.3% | -44.3% | 0.00 | 8.45 | -3.0 |
| 31 Dec 2016 | FY | 100.0% | -3645.2% | -52.9% | -40.8% | 0.00 | 10.47 | -2.4 |
| -6.7 |
| 30 Sept 2025 | Q3 | 95.4% | -132.4% | -52.6% | -11.0% | 2.99 | 4.64 | -5.5 |
| 30 Jun 2025 | Q2 | 96.6% | -189.3% | -45.6% | -12.1% | 0.01 | 4.71 | -2.8 |
| 31 Mar 2025 | Q1 | 95.6% | -423.3% | -39.5% | -13.2% | 0.01 | 5.80 | -3.1 |
| 31 Dec 2024 | Q4 | 100.0% | -1226.2% | -32.7% | -13.0% | 1.20 | 5.82 | -3.0 |
| 30 Sept 2024 | Q3 | 100.0% | -673.0% | -23.0% | -19.8% | 0.00 | 6.99 | -4.9 |
| 30 Jun 2024 | Q2 | 100.0% | -1944.7% | -15.7% | -14.3% | 0.00 | 10.50 | -6.7 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -14.7% | -13.3% | 0.00 | 8.93 | -7.0 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -13.1% | -11.8% | 0.00 | 10.00 | -5.4 |